当前位置:首页 - 行情中心 - 国际医学(000516) - 财务分析

国际医学

(000516)

  

流通市值:108.09亿  总市值:109.85亿
流通股本:22.24亿   总股本:22.60亿

国际医学(000516)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-2.94亿元,每股收益-0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益347852.60万元,未分配利润6199.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1055406.69万元,负债707554.08万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入3,606,256,924.422,420,461,714.171,172,923,244.524,617,873,479.43
营业总成本3,892,721,588.982,605,523,886.631,286,778,395.155,141,769,803.58
营业利润-283,406,415.63-221,065,009.13-128,444,926.09-462,022,038.54
利润总额-283,483,908.67-220,807,795.14-128,481,902.94-467,254,360.64
净利润-294,272,771.9-228,824,807.08-131,877,100.92-471,948,805.27
其他综合收益----
综合收益总额-294,272,771.9-228,824,807.08-131,877,100.92-471,948,805.27
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,461,576,314.491,553,510,887.291,636,434,285.691,912,895,613.76
非流动资产合计9,092,490,561.889,193,289,174.329,275,647,915.199,408,240,198.01
资产总计10,554,066,876.3710,746,800,061.6110,912,082,200.8811,321,135,811.77
流动负债合计3,931,333,257.163,907,509,954.043,834,835,151.814,115,838,160.39
非流动负债合计3,144,207,591.433,296,919,635.823,384,589,792.463,389,206,959.44
负债合计7,075,540,848.597,204,429,589.867,219,424,944.277,505,045,119.83
归属于母公司股东权益合计3,652,616,319.13,689,515,938.423,811,548,583.53,908,017,195.19
股东权益合计3,478,526,027.783,542,370,471.753,692,657,256.613,816,090,691.94
负债和股东权益合计10,554,066,876.3710,746,800,061.6110,912,082,200.8811,321,135,811.77
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计3,544,589,105.112,432,223,017.831,221,898,669.414,704,988,828.18
经营活动现金流出小计2,920,901,989.241,906,709,123.771,002,651,749.473,617,654,441.77
经营活动产生的现金流量净额623,687,115.87525,513,894.06219,246,919.941,087,334,386.41
投资活动现金流入小计52,055,463.6352,040,463.6352,040,463.6326,756,744.01
投资活动现金流出小计458,211,576.8365,739,907.06189,476,696.84788,756,641.38
投资活动产生的现金流量净额-406,156,113.17-313,699,443.43-137,436,233.21-761,999,897.37
筹资活动现金流入小计557,630,000455,430,000199,400,000796,764,689.62
筹资活动现金流出小计1,291,640,695.1943,947,955.63483,009,925.441,361,914,650.09
筹资活动产生的现金流量净额-734,010,695.1-488,517,955.63-283,609,925.44-565,149,960.47
汇率变动对现金及现金等价物的影响--0-
现金及现金等价物净增加额-516,479,692.4-276,703,505-201,799,238.71-239,815,471.43
期末现金及现金等价物余额427,482,946.42667,259,133.82742,163,400.11943,962,638.82
最新报告期:2024-11-09
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华创证券郑辰,王宏雨-0.090.000.082024-11-09
中信证券陈竹-0.010.080.172024-10-29
东海证券伍可心,杜永宏-0.10-0.020.042024-10-28
TOP↑